Citius Pharmaceuticals, Inc. Proceeds from Issuance of Debt
Citius Pharmaceuticals, Inc. (CTXR) reported Proceeds from Issuance of Debt of $10.00 million for the 12-month period ending 2016-09-30, per its 10-K filed 2016-12-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2016-12-23
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2014-06-30 was $4.99K, a 61.92% decline year-over-year.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2014-03-31 was $3.48K.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2013-12-31 was $17.52K, a 8661.50% increase year-over-year.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for the quarter ending 2013-09-30 was $3.20K, a 77.32% decline year-over-year.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for fiscal 2016 was $10.00M.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for fiscal 2013 was $16.30K, a 4.38% decline from fiscal 2012.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for fiscal 2012 was $17.05K.
- Citius Pharmaceuticals, Inc. proceeds from issuance of debt for fiscal 2011 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 6 month as first filed | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month | Proceeds from Issuance of Debt 22 month | Proceeds from Issuance of Debt 25 month | Proceeds from Issuance of Debt 28 month | Proceeds from Issuance of Debt 31 month | Proceeds from Issuance of Debt 34 month | Proceeds from Issuance of Debt 37 month | Proceeds from Issuance of Debt 40 month | Proceeds from Issuance of Debt 43 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $10.00M 10-K · filed 2016-12-23 | ||||||||||||
| 2014-06-30 | $4.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | $8.47K derived: sum of 2 quarters · filed 2014-08-14 | $26.00K 10-Q · filed 2014-08-14 | $29.20K derived: sum of 4 quarters · filed 2014-08-14 | |||||||||
| 2014-03-31 | $3.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $21.01K 10-Q · filed 2014-05-15 | $24.21K derived: sum of 3 quarters · filed 2014-05-15 | $37.31K derived: sum of 4 quarters · filed 2014-08-14 | $54.35K 10-Q · filed 2014-05-15 | ||||||||
| 2013-12-31 | $17.52K 10-Q · filed 2014-02-19 | $20.72K derived: sum of 2 quarters · filed 2014-02-19 | $33.82K derived: sum of 3 quarters · filed 2014-08-14 | $33.62K derived: sum of 4 quarters · filed 2014-08-14 | $50.87K 10-Q · filed 2014-02-19 | ||||||||
| 2013-09-30 | $3.20K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $16.30K derived: sum of 2 quarters · filed 2014-08-14 | $16.10K derived: sum of 3 quarters · filed 2014-08-14 | $16.30K 10-K · filed 2014-02-06 | $33.35K 10-K · filed 2014-02-06 | ||||||||
| 2013-06-30 | $13.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | $12.90K derived: sum of 2 quarters · filed 2014-08-14 | $13.10K 10-Q · filed 2014-08-14 | $27.21K derived: sum of 4 quarters · filed 2014-08-14 | $30.15K 10-Q · filed 2013-09-18 | ||||||||
| 2013-03-31 | -$200.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | $9.90K 10-Q · filed 2013-05-13 | $14.11K derived: sum of 3 quarters · filed 2014-05-15 | $17.05K derived: sum of 4 quarters · filed 2014-05-15 | $26.95K 10-Q · filed 2013-05-13 | |||||||
| 2012-12-31 | $200.00 10-Q · filed 2014-02-19 | $14.31K derived: sum of 2 quarters · filed 2014-02-19 | $17.25K derived: sum of 3 quarters · filed 2014-02-19 | $17.25K derived: sum of 4 quarters · filed 2014-02-19 | $17.25K 10-Q · filed 2013-02-08 | ||||||||
| 2012-09-30 | $14.11K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $17.05K derived: sum of 2 quarters · filed 2014-02-06 | $17.05K derived: sum of 3 quarters · filed 2014-02-06 | $17.05K 10-K · filed 2014-02-06 | $17.05K 10-K · filed 2013-01-15 | ||||||||
| 2012-06-30 | $2.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-18 | $2.94K derived: sum of 2 quarters · filed 2013-09-18 | $2.94K 10-Q · filed 2013-09-18 | $2.94K 10-Q · filed 2012-08-17 | |||||||||
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-13 | $0.00 10-Q · filed 2013-05-13 | |||||||||||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-08 | ||||||||||||
| 2011-09-30 | $0.00 10-K · filed 2013-01-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |